NCT03008876 is a NA clinical trial of Acetaminophen in Patent Ductus Arteriosus, sponsored by Albany Medical College.

Who is sponsoring NCT03008876?

NCT03008876 is sponsored by Albany Medical College.

What drugs are being tested in NCT03008876?

Interventions in NCT03008876: Acetaminophen, Ibuprofen.

What condition does NCT03008876 study?

NCT03008876 studies Patent Ductus Arteriosus.

Is NCT03008876 still recruiting?

NCT03008876 is currently completed. Last updated 8 July 2019.

Last reviewed 2019-07-08 · How we verify

NCT03008876

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

IV Acetaminophen and Patent Ductus Arteriosus

Completed NA Last updated 8 July 2019

What this trial tests

NA trial testing Acetaminophen in Patent Ductus Arteriosus in 10 participants. Completed in 30 June 2019.

Timeline

1 January 2017

Primary endpoint
30 June 2019

30 June 2019

Quick facts

Lead sponsor	Albany Medical College
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	10
Start date	1 January 2017
Primary completion	30 June 2019
Estimated completion	30 June 2019
Sites	1 location across United States

Drugs / interventions tested

Acetaminophen (Paracetamol) — full drug profile →
Ibuprofen (ibuprofen) — full drug profile →

Conditions studied

Patent Ductus Arteriosus — all drugs for Patent Ductus Arteriosus →

Sponsor

Albany Medical College

Who can join

Adults 1 Minute to 2 Weeks, any sex, with Patent Ductus Arteriosus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized controlled trial to evaluate the efficacy of IV acetaminophen versus IV ibuprofen in closing a hemodynamically significant patent ductus arteriosus in preterm infants.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants.
Ohlsson A, Shah PS. · · 2018 · cited 64× · PMID 29624206 · DOI 10.1002/14651858.cd010061.pub3
Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants.
Ohlsson A, Shah PS. · · 2020 · cited 59× · PMID 31985831 · DOI 10.1002/14651858.cd010061.pub4
The molecular mechanisms of cardiac development and related diseases.
Li Y, Du J, Deng S, Liu B, et al · · 2024 · cited 53× · PMID 39715759 · DOI 10.1038/s41392-024-02069-8
Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants.
Jasani B, Mitra S, Shah PS. · · 2022 · cited 22× · PMID 36519620 · DOI 10.1002/14651858.cd010061.pub5
Intravenous acetaminophen vs intravenous ibuprofen to close a patent ductus arteriosus closure: A pilot randomized controlled trial.
Tauber KA, King R, Colon M. · · 2020 · cited 11× · PMID 32775700 · DOI 10.1002/hsr2.183

Verify or expand the search:

Other trials of Acetaminophen

Trials testing the same drug.

NCT07502001 — Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin · Phase 1 · not yet recruiting
NCT07525791 — A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not A · Phase 1 · not yet recruiting
NCT07508241 — A Study to Learn About the Effect of Study Medicine Called PF-08653944 on How Quickly the Stomach Empties Its Content in · Phase 1 · not yet recruiting
NCT06994442 — Optimizing Pain Treatment in Children On Mechanical Ventilation · Phase 3 · recruiting
NCT07101445 — Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injecti · Phase 4 · recruiting

Other recruiting trials for Patent Ductus Arteriosus

Currently open trials in the same condition.

NCT06646250 — NeoDoppler: New Ultrasound Technology for Continuous Monitoring of Cerebral Circulation Pilot · recruiting
NCT05264753 — Post Marketing Clinical Follow Up Study to Evaluate Efficacy and Safety of the Occlutech PDA Occluder in Patients With P · recruiting
NCT04371081 — Amplatzer Piccolo Occluder Japan Post-marketing Database Surveillance · active not recruiting
NCT03456336 — Management of the PDA Trial · Phase 3 · active not recruiting

Other Albany Medical College trials

Trials by the same sponsor.

NCT07373093 — Predictors of Measles Vaccine Hesitancy in New York State · completed
NCT06517901 — Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer · NA · recruiting
NCT06668766 — Single Lumen Midline Catheter vs Long Peripheral Intravenous Cather for Difficult Intravenous Access in the ED · NA · recruiting
NCT06677541 — Vibrator Use to Improve Sexual and Pelvic Floor Function Among Urogynecology Patients · NA · recruiting
NCT02703610 — Randomized Trial of Two Analgesics in Elderly ED Patients · Phase 4 · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03008876 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Albany Medical College
Last refreshed: 8 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03008876.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing